関連する実験動画

Updated: Feb 13, 2026

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

甘いサプライズ:がんの進行と治療の可能性における腫瘍関連グリコシレーションの解読

Eileena F Giurini¹, Sam G Pappas², Kajal H Gupta^1,2,3

¹Division of Pediatric Oncology, Department of Surgery, RUSH University Medical Center, Chicago, IL 60612, USA.

|February 12, 2026

まとめ

腫瘍関連グリコシレーションは,がんの進行と腫瘍の微小環境に大きな影響を及ぼします. グライカンを標的とする治療法は,これらの異常なグライカンの構造を調節することによって,癌と闘うための特定の新しいアプローチを提供します.

科学分野:

腫瘍学腫瘍学
グライコバイオロジーは,
癌生物学癌生物学について

背景:

腫瘍関連グリコシレーションは,がんの主要な特徴であり,細胞表面構造と機能を変化させます.
異常なグリコシライゼーションは,腫瘍細胞の増殖,侵入,転移,および免疫回避と血管新生を含む腫瘍の微環境に影響します.

研究の目的:

腫瘍発生における制御不良のグリカンモチーフとそのメカニズムをレビューする.
がんに関連するグリカンとバイオマーカーを標的とした治療の機会を強調する.

主な方法:

腫瘍関連グリコシル化に関する文献レビュー.
ガンの病原性におけるグリカン改変の役割の分析.
グライカンを標的とする治療戦略の探索.

主要な成果:

異常なグリコシライゼーションは,腫瘍細胞の増殖,侵入,転移を高める.
変化したグリカンは腫瘍の微環境を調節し,免疫応答と血管新生に影響を与えます.
グライカンを標的とする治療法では,特異性と免疫脱出の克服が有望であることが示されています.

結論:

グライコシライゼーションは,がん生物学の中心であり,有効な治療目標である.
グライカン標的薬は,チェックポイントブロックなどの既存の治療法を補完することができます.
グライカンプロファイルを利用したバイオマーカー主導の戦略は,がんの診断と治療に役立ちます.

キーワード:

癌のグルイコ生物学癌免疫療法免疫療法グライカンを標的とするがん治療法シアライレーションとSiglecシグナリング腫瘍のマイクロ環境

さらに関連する動画

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

関連する概念動画

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Protein Glycosylation

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...